Benjamin Shiff1, Udi Blankstein2, Jafar Hussaen2, Keith Jarvi3, Ethan Grober4, Kirk Lo3, Katherine Lajkosz5, Yonah Krakowsky4. 1. Section of Urology, Department of Surgery, University of Manitoba, Winnipeg, MB, Canada. 2. Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada. 3. Division of Urology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. 4. Division of Urology, Department of Surgery, Women's College Hospital and Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. 5. University Health Network, Toronto, ON, Canada.
Abstract
INTRODUCTION: Despite increasing consumption rates in much of the world, the impact of cannabis use on various components of male sexual function remains poorly established. The purpose of this study was to further evaluate the relationship between cannabis use and reproductive and sexual function using a large patient cohort from a single academic andrology clinic. METHODS: This is a historical cohort study from a single academic center andrology clinic. Patients from 2008-2017 were included. Intake questionnaires provided baseline demographic information, as well as data regarding substance use and various sexual function parameters. Subjects were categorized as cannabis users or non-users. Cannabis users and non-users were compared using descriptive statistics and Chi-squared tests, and regression analyses were performed to test for association. RESULTS: A total of 7809 males were included in the study; 993 (12.7%) were cannabis users and 6816 (87.3%) were non-users. Cannabis users had a higher mean Sexual Health Inventory for Men (SHIM) score (21.9±4.4 vs. 21.2±4.8, p<0.001) and mean serum total testosterone (13.4±12.0 nmol/L vs. 12.6±11.8 nmol/L, p=0.04) than non-users, although they also had a higher rate of positive Androgen Deficiency in the Aging Male (ADAM) scores (52% vs. 46%, p<0.001). Cannabis users also reported higher sexual frequency compared to non-users (8.8 events/month vs. 7.8 events/month, p<0.05). On multivariate analysis, cannabis use was not associated with SHIM score or serum testosterone concentration. Cannabis use was associated with positive ADAM scores. CONCLUSIONS: Cannabis use was not associated with clinically significant deleterious effects on male sexual parameters in this cohort.
INTRODUCTION: Despite increasing consumption rates in much of the world, the impact of cannabis use on various components of male sexual function remains poorly established. The purpose of this study was to further evaluate the relationship between cannabis use and reproductive and sexual function using a large patient cohort from a single academic andrology clinic. METHODS: This is a historical cohort study from a single academic center andrology clinic. Patients from 2008-2017 were included. Intake questionnaires provided baseline demographic information, as well as data regarding substance use and various sexual function parameters. Subjects were categorized as cannabis users or non-users. Cannabis users and non-users were compared using descriptive statistics and Chi-squared tests, and regression analyses were performed to test for association. RESULTS: A total of 7809 males were included in the study; 993 (12.7%) were cannabis users and 6816 (87.3%) were non-users. Cannabis users had a higher mean Sexual Health Inventory for Men (SHIM) score (21.9±4.4 vs. 21.2±4.8, p<0.001) and mean serum total testosterone (13.4±12.0 nmol/L vs. 12.6±11.8 nmol/L, p=0.04) than non-users, although they also had a higher rate of positive Androgen Deficiency in the Aging Male (ADAM) scores (52% vs. 46%, p<0.001). Cannabis users also reported higher sexual frequency compared to non-users (8.8 events/month vs. 7.8 events/month, p<0.05). On multivariate analysis, cannabis use was not associated with SHIM score or serum testosterone concentration. Cannabis use was associated with positive ADAM scores. CONCLUSIONS: Cannabis use was not associated with clinically significant deleterious effects on male sexual parameters in this cohort.
Authors: Anthony M A Smith; Jason A Ferris; Judy M Simpson; Julia Shelley; Marian K Pitts; Juliet Richters Journal: J Sex Med Date: 2009-08-17 Impact factor: 3.802
Authors: Renata K Carvalho; Maingredy R Souza; Monaliza L Santos; Francisco S Guimarães; Roger Luís H Pobbe; Monica L Andersen; Renata Mazaro-Costa Journal: Reprod Toxicol Date: 2018-06-21 Impact factor: 3.143
Authors: Damiano Pizzol; Jacopo Demurtas; Brendon Stubbs; Pinar Soysal; Corina Mason; Ahmet Turan Isik; Marco Solmi; Lee Smith; Nicola Veronese Journal: Am J Mens Health Date: 2019 Nov-Dec
Authors: Pablo Roman; Ana Ortiz-Rodriguez; Ana Romero-Lopez; Miguel Rodriguez-Arrastia; Carmen Ropero-Padilla; Nuria Sanchez-Labraca; Lola Rueda-Ruzafa Journal: Healthcare (Basel) Date: 2021-12-31